Methodology of a multistate study of congenital hearing loss: Preliminary data from Utah newborn screening

A multistate Centers for Disease Control and Prevention (CDC) study was designed to investigate the etiology of congenital hearing loss in infants ascertained through state‐mandated hearing screening or early hearing loss detection and intervention (EHDI) programs. At least 50% of permanent childhood‐onset hearing loss is due to genetic causes, and approximately 20% of all infants with congenital hearing loss have mutations in the GJB2 gene. Another 1% of childhood hearing loss is due to mitochondrial DNA (mtDNA) mutations. The specific aims of this study are to 1) classify the etiology of congenital hearing loss in infants by doing prospective genetic evaluations of all newborns with permanent hearing loss from defined geographic areas, 2) determine the frequency of mutations in GJB2 and two common mitochondrial mutations in these populations, and 3) establish a model infrastructure linking genetic services to statewide EHDI programs. As of April 2003, Utah is the only center evaluating patients. Study subjects identified through the Utah Department of Health EHDI program are contacted by letter and offered a comprehensive medical genetics evaluation with DNA testing for GJB2 and mitochondrial mutations A1555G and A7445G. To date, 25 probands and their immediate family members have been evaluated. We have identified 20 cases with nonsyndromic hearing loss (7 multiplex and 13 simplex), 4 with syndromic hearing loss, and 1 with presumed cytomegalovirus (CMV)‐induced hearing loss. Six of 19 (32%) nonsyndromic cases with sensorineural hearing loss have mutations of one or both alleles of the GJB2 gene, and 21% are homozygous or compound heterozygotes for the 35delG mutation. No A1555G or A7445G mtDNA mutations have been found. Data reported to date include only children born in Utah, but EHDI programs in Hawaii, Rhode Island, and designated areas of Georgia have begun enrolling children in what is now a multistate collaborative study. This is the first comprehensive investigation to determine the etiology of hearing loss from populations ascertained through EHDI programs. The results of this study will facilitate the incorporation of genetic services into EHDI programs. © 2004 Wiley‐Liss, Inc.

[1]  M. Barbi,et al.  A wider role for congenital cytomegalovirus infection in sensorineural hearing loss , 2003, The Pediatric infectious disease journal.

[2]  A. Kenneson,et al.  GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: A HuGE review , 2002, Genetics in Medicine.

[3]  V. Sheffield,et al.  Performance of cochlear implant recipients with GJB2-related deafness. , 2002, American journal of medical genetics.

[4]  F. Moreno,et al.  A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. , 2002, The New England journal of medicine.

[5]  K. Arnos,et al.  Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss , 2002, Genetics in Medicine.

[6]  C. Morton,et al.  At the speed of sound: gene discovery in the auditory system. , 2001, American journal of human genetics.

[7]  I. Schafer.  High-Frequency Hearing Loss Correlated With Mutation in the GJB2 Gene , 2001 .

[8]  Welfare Agencies,et al.  Year 2000 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs , 2000, Pediatrics.

[9]  Welfare Agencies,et al.  Year 2000 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs. , 2000, American journal of audiology.

[10]  S. Iwasaki,et al.  Hereditary Sensorineural Hearing Loss of Unknown Cause Involving Mitochondrial DNA 1555 Mutation , 2000, ORL.

[11]  B. Vohr,et al.  Connexin-26 gene analysis in hearing-impaired newborns. , 2000, Genetic testing.

[12]  R. Williamson,et al.  High frequency hearing loss correlated with mutations in the GJB2 gene , 2000, Human Genetics.

[13]  S. Dimauro,et al.  Maternally inherited nonsyndromic hearing loss. , 1999, American journal of medical genetics.

[14]  C. Petit,et al.  Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling , 1999, The Lancet.

[15]  G. B. Schaefer,et al.  Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1) , 1999, Pediatrics.

[16]  N. Fischel‐Ghodsian.  Mitochondrial deafness mutations reviewed , 1999, Human mutation.

[17]  X. Estivill,et al.  Connexin-26 mutations in sporadic and inherited sensorineural deafness , 1998, The Lancet.

[18]  C. Petit,et al.  Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. , 1997, Human molecular genetics.

[19]  X. Estivill,et al.  Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. , 1997, Human molecular genetics.

[20]  P. Willems,et al.  Nonsyndromic hearing impairment: unparalleled heterogeneity. , 1997, American journal of human genetics.

[21]  G. Camp,et al.  The hereditary hearing loss homepage , 1997 .

[22]  H. Wanamaker,et al.  Hereditary hearing loss and its syndromes , 1996 .

[23]  W. Reardon,et al.  Hereditary Hearing Loss and its Syndromes , 1995 .

[24]  K. Arnos.  Hereditary Hearing Loss , 1994 .

[25]  S. Kahler,et al.  The Genetic Basis of Common Diseases , 1993 .

[26]  K. Arnos,et al.  Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. , 1993, American journal of medical genetics.

[27]  N. E. MORTON,et al.  Genetic Epidemiology of Hearing Impairment , 1991, Annals of the New York Academy of Sciences.

[28]  G. Fraser.  The Causes of Profound Deafness in Childhood: A Study of 3,535 Individuals with Severe Hearing Loss Present at Birth or of Childhood Onset , 1976 .